Up on AVB's website http://www.avancoresources.com/content/wp-content/uploads/2017/04/Euroz31Mar17.pdf well worth a read. There are a few other brokers updating their recommendations and price targets as well.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%